ライフサイエンスコーパス: primitive neuroectodermal tumor

1 ie, atypical teratoid/rhabdoid tumor and CNS primitive neuroectodermal tumor).

2 in's tumor of the chest wall, and peripheral primitive neuroectodermal tumor.

3 imilar to the neuroblastic rosettes in human primitive neuroectodermal tumors.

4 ver, it is also thought to be etiological in primitive neuroectodermal tumors.

5 mosomal translocation in Ewing's sarcoma and primitive neuroectodermal tumors.

6 2 with pancreaticoblastomas and 1 of 10 with primitive neuroectodermal tumors.

7 ld be a common mechanism in the causation of primitive neuroectodermal tumors.

8 Among sarcomas, 21 of 21 Ewing's/primitive neuroectodermal tumor, 28 of 29 rhabdomyosarco

9 e beginning of treatment: medulloblastoma or primitive neuroectodermal tumors, 57.8; germ cell tumors

10 own to be involved in Ewing sarcoma, related primitive neuroectodermal tumors and desmoplastic small

11 ial response (PR) in two patients with Ewing/primitive neuroectodermal tumors and included one PR and

12 rs (16 osteosarcomas, one Ewing sarcoma, one primitive neuroectodermal tumor, and one desmoplastic sm

13 velopment of gliomas, central nervous system primitive neuroectodermal tumors, and atypical teratoid/

14 sk medulloblastomas (MBs) and supratentorial primitive neuroectodermal tumors, and we report the outc

15 hich comprise Ewing's sarcoma and peripheral primitive neuroectodermal tumors, are highly aggressive

16 umors with multilayered rosettes (ETMRs) are primitive neuroectodermal tumors arising in infants.

17 d unpublished GEM models of medulloblastoma, primitive neuroectodermal tumor, astrocytoma, oligodendr

18 ), undifferentiated sarcoma, and soft tissue primitive neuroectodermal tumor at all sites except para

19 and primary SCLC cultures as well as in some primitive neuroectodermal tumor biopsies.

20 Using a human peripheral primitive neuroectodermal tumor cell line, SK-N-MC, we d

21 ety of substrates, in contrast to cells from primitive neuroectodermal tumors cells (n=6), which only

22 had low-grade glioma, 32 had medulloblastoma/primitive neuroectodermal tumor/embryonal tumor, 17 had

23 For medulloblastoma, supratentorial primitive neuroectodermal tumor, ependymoma, and rhabdoi

24 ve outcomes of patients with Ewing's sarcoma/primitive neuroectodermal tumor (ES/PNET) metastatic to

25 Ewings sarcoma and primitive neuroectodermal tumors (ES/PNET) are character

26 Primary renal primitive neuroectodermal tumor/extraskeletal Ewing's sa

27 I-1, the hallmark of the Ewing's sarcoma and primitive neuroectodermal tumor family, encodes a fusion

28 ted to a single cell type (two patients with primitive neuroectodermal tumors, five with undifferenti

29 iction should raise the suspicion of a renal primitive neuroectodermal tumor, in a young adult.

30 LI1 fusion gene found in Ewing's sarcoma and primitive neuroectodermal tumor, is able to transform ce

31 roglial-containing tumors, brain lymphoma or primitive neuroectodermal tumor make use of systemic adm

32 Since primitive neuroectodermal tumors/medulloblastomas (PNETs

33 ients had foci of yolk sac tumor (n = 21) or primitive neuroectodermal tumor (n = 2), whereas 50 had

34 (n = 6), ependymoma (n = 8), medulloblastoma/primitive neuroectodermal tumor (n = 4), glioblastoma mu

35 nd those without a bone sarcoma (ie, neither primitive neuroectodermal tumor nor osteosarcoma) (HR fo

36 Ewing's sarcoma and primitive neuroectodermal tumor of bone are closely rela

37 ffective in patients with Ewing's sarcoma or primitive neuroectodermal tumor of bone who had a relaps

38 patients with nonmetastatic Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sa

39 0 years old or younger with Ewing's sarcoma, primitive neuroectodermal tumor of bone, or primitive sa

40 Primitive neuroectodermal tumors of the central nervous

41 Patients < or = 30 years with Ewing sarcoma, primitive neuroectodermal tumor or primitive sarcoma of

42 ) in children treated for medulloblastoma or primitive neuroectodermal tumor (PNET) and document the

43 all cases of Ewing's Sarcoma and peripheral Primitive Neuroectodermal Tumor (PNET) are associated wi

44 Medulloblastoma (MB) and primitive neuroectodermal tumor (PNET) are histologicall

45 of FDG PET imaging of brain involvement with primitive neuroectodermal tumor (PNET) demonstrated mild

46 a (NB) and the Ewing sarcoma (ES)/peripheral primitive neuroectodermal tumor (PNET) family are pediat

47 patients with metastatic Ewing's sarcoma or primitive neuroectodermal tumor (PNET) of bone were ente

48 s of medulloblastoma, central nervous system primitive neuroectodermal tumor (PNET), and astrocytoma

49 diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumor (PNET).

50 f pediatric patients with medulloblastoma or primitive neuroectodermal tumor (PNET).

51 Ten of 20 (50%) patients (primitive neuroectodermal tumor (PNET)/medulloblastoma,

52 one [osteogenic (OS) and Ewing's (ES) and/or primitive neuroectodermal tumor (PNET)] sarcoma, treated

53 astrocytoma and 158 children diagnosed with primitive neuroectodermal tumors (PNET) in the United St

54 moter developed bilateral retinoblastoma and primitive neuroectodermal tumors (PNET) of the midbrain.

55 ly (ESFT), such as Ewing's sarcoma (EWS) and primitive neuroectodermal tumors (PNET), are highly aggr

56 transgenic mice to the human medulloblastoma/primitive neuroectodermal tumor (PNETs) in location, his

57 Primitive neuroectodermal tumors (PNETs) are a family of

58 Primitive neuroectodermal tumors (PNETs) of the central

59 Primitive neuroectodermal tumors (PNETs) of the central

60 enetic lesions in medulloblastomas and other primitive neuroectodermal tumors (PNETs) of the childhoo

61 E SCUTE 1 (HASH1) in cerebellar and cerebral primitive neuroectodermal tumors (PNETs), gliomas, and c

62 mice leads to the development of cerebellar primitive neuroectodermal tumors (PNETs).

63 , cerebral neuroblastoma, pineoblastoma, and primitive neuroectodermal tumors (PNETs).

64 ith high-grade glioma and in two of six with primitive neuroectodermal tumors (PNETs)/ medulloblastom

65 response (PR) in one patient with peripheral primitive neuroectodermal tumor (PPNET), and a minimal r

66 We have analyzed a primitive neuroectodermal tumor sample exhibiting loss o

67 , classically Ewing's sarcoma and peripheral primitive neuroectodermal tumor, share a common class of

68 lastoma, whereas experimental supratentorial primitive neuroectodermal tumors (sPNET) correspond to a

69 valuation of a panel of human supratentorial primitive neuroectodermal tumors (sPNET) showed low acti

70 o develop a new approach to the treatment of primitive neuroectodermal tumors we evaluated the effect

71 nd brain stem NSCs generated medulloblastoma/primitive neuroectodermal tumors, whereas forebrain NSCs

72 d transgenic animals that develop cerebellar primitive neuroectodermal tumors which model human medul

73 Cs were transformed with N-Myc, we generated primitive neuroectodermal tumors with divergent differen